AxoGen (NASDAQ:AXGN – Get Free Report) had its target price boosted by equities researchers at Citizens Jmp from $50.00 to $55.00 in a report released on Thursday,Benzinga reports. Truist Financial set a $55.00 target price on shares of AxoGen in a research report on Thursday. Finally, Jefferies Financial Group reissued a “buy” rating and set a $55.00 target price on shares of AxoGen in a research note on Wednesday. According to MarketBeat, AxoGen currently has a consensus rating of “Moderate Buy” and an average target price of $50.44. Insider Buying and Selling at AxoGenIn other AxoGen news, Director Amy Mcbride Wendell sold 1,647 shares of AxoGen stock in a transaction on Friday, May 8th.